人参皂苷 20(S)-Rg3 通过调控 miR-324-5p 靶向 PSME3 抑制食管鳞癌细胞活力。
Ginsenoside 20(S)-Rg3 suppresses cell viability in esophageal squamous cell carcinoma via modulating miR-324-5p-targeted PSME3.
机构信息
Department of Pathology, Taizhou People's Hospital Affiliated to Nanjing University of Chinese Medicine, Taizhou, Jiangsu, China.
Institute of Clinical Medicine, Taizhou People's Hospital Affiliated to Nanjing University of Chinese Medicine, Taizhou, Jiangsu, China.
出版信息
Hum Exp Toxicol. 2021 Nov;40(11):1974-1984. doi: 10.1177/09603271211017311. Epub 2021 May 18.
Ginsenoside 20(S)-Rg3 is identified as an active saponin monomer which derived from red ginseng and is demonstrated to play an anti-tumor role in diverse cancers. MicroRNAs (miRNAs) are important regulators in the progression of cancers, containing esophageal squamous cell carcinoma (ESCC). It was reported that microRNA 324-5p (miR-324-5p) exerted critical functions in some cancers; however, the detailed molecular mechanism of miR-324-5p mediated by 20(S)-Rg3 to suppress cell viability in ESCC has not been explored. Herein, we explored the function of 20(S)-Rg3 or miR-324-5p on ESCC cell viability by MTT assay, colony formation assay, flow cytometry analysis and western blot analysis. The binding of miR-324-5p to its target gene, proteasome activator subunit 3 (PSME3), was confirmed through RNA pull down and luciferase reporter assays. The results indicated that 20(S)-Rg3 significantly inhibited cell viability and the cell cycle and facilitated cell apoptosis. Furthermore, this effect was strengthened with the increased concentration of 20(S)-Rg3. Moreover, we found that miR-324-5p level was increased under 20(S)-Rg3 treatment. Additionally, overexpressed miR-324-5p inhibited ESCC cell viability, and downregulated miR-324-5p recovered inhibited cell viability caused by 20(S)-Rg3. Further exploration verified that miR-324-5p targeted PSME3, and PSME3 deficiency countervailed the effect of miR-324-5p inhibition on ESCC cell viability under 20(S)-Rg3 treatment. Conclusively, 20(S)-Rg3 suppresses cell viability in ESCC via mediating miR-324-5p-targeted PSME3.
人参皂苷 20(S)-Rg3 被鉴定为一种从红参中衍生的活性皂苷单体,被证明在多种癌症中发挥抗肿瘤作用。微小 RNA(miRNA)是癌症进展中的重要调节因子,包括食管鳞状细胞癌(ESCC)。有报道称,微小 RNA 324-5p(miR-324-5p)在一些癌症中发挥着关键作用;然而,20(S)-Rg3 通过 miR-324-5p 介导来抑制 ESCC 细胞活力的详细分子机制尚未被探索。在这里,我们通过 MTT 测定、集落形成测定、流式细胞术分析和 Western blot 分析来研究 20(S)-Rg3 或 miR-324-5p 对 ESCC 细胞活力的作用。通过 RNA 下拉和荧光素酶报告基因测定证实了 miR-324-5p 与其靶基因蛋白酶体激活剂亚基 3(PSME3)的结合。结果表明,20(S)-Rg3 显著抑制细胞活力和细胞周期,并促进细胞凋亡。此外,这种作用随着 20(S)-Rg3 浓度的增加而增强。此外,我们发现 20(S)-Rg3 处理后 miR-324-5p 水平升高。此外,过表达 miR-324-5p 抑制 ESCC 细胞活力,下调 miR-324-5p 恢复 20(S)-Rg3 引起的抑制细胞活力。进一步的探索验证了 miR-324-5p 靶向 PSME3,并且 PSME3 缺失抵消了 miR-324-5p 抑制对 20(S)-Rg3 处理下 ESCC 细胞活力的影响。总之,20(S)-Rg3 通过介导 miR-324-5p 靶向 PSME3 来抑制 ESCC 细胞活力。